A Wake-up Call for Type 2 Diabetes? | NEJM
Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes | NEJM
Open-Source Automated Insulin Delivery in Type 1 Diabetes | NEJM
Molecular Mechanisms and Clinical Pathophysiology of Maturity-Onset Diabetes of the Young | NEJM
Trends in Diabetes Treatment and Control in U.S. Adults, 1999–2018 | NEJM
Lower versus Higher Glycemic Criteria for Diagnosis of Gestational Diabetes | NEJM
Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes | NEJM
Diabetic Retinopathy | NEJM
Supplying Insulin while Evading Immunity | NEJM
Evaluation and Care of Patients with Diabetic Retinopathy | NEJM
Current Management of Glycemia in Children with Type 1 Diabetes Mellitus | NEJM
Diagnosis of Diabetes | NEJM
Nephron Protection in Diabetic Kidney Disease | NEJM
Diabetic Foot Ulcers and Their Recurrence | NEJM
Gastric Emptying Abnormalities in Diabetes Mellitus | NEJM
Glycemic Management of Type 2 Diabetes Mellitus | NEJM
Genetics of Type 1A Diabetes | NEJM
Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes | NEJM
Insulin-Pump Therapy for Type 1 Diabetes Mellitus | NEJM
Adipocyte Regulation of Insulin Sensitivity and the Risk of Type 2 Diabetes | NEJM
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes | NEJM
The Past 200 Years in Diabetes | NEJM
Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes | NEJM
Islet Amyloid and Type 2 Diabetes Mellitus | NEJM
